$2M GreenLight Biosciences Merger Settlement, Are You Eligible to Claim Your Share? Must File a Claim by July 29, 2026

If you held GreenLight Biosciences Holdings (GRNA) common stock between June 21 and July 20, 2023, and received just $0.30 per share when the company was acquired, a $2,000,000 class action settlement now lets you recoup a portion of that payout. Stockholders must file a claim by July 29, 2026. The fairness hearing is scheduled for June 29, 2026 in the Delaware Court of Chancery.

Quick Facts

Field	Detail
Settlement Amount	$2,000,000
Claim Deadline	July 29, 2026
Who Qualifies	Record and beneficial holders of GRNA stock between June 21–July 20, 2023, cashed out at $0.30/share
Payout Per Person	Estimated ~$0.04 per share (net, after fees and expenses)
Proof Required	Yes — broker statements or trade confirmations showing share holdings
Settlement Status	Proposed — Fairness Hearing June 29, 2026
Case Number	2024-1020-KSJM
Administrator	RG/2 Claims Administration LLC
Official Website	rg2claims.com/greenlight.html

Settlement Status & What Happens Next

• Proposed settlement in In re GreenLight Bio Merger Stockholder Litigation (Lead C.A. No. 2024-1020-KSJM), Delaware Court of Chancery — fairness hearing set for June 29, 2026 at 1:30 p.m., held in person in Wilmington, Delaware or remotely by Zoom at the Court’s discretion.
• Objection deadline is June 15, 2026 — class members who want to challenge the settlement terms or fee request must submit written objections to the Court by this date.
• This is a non-opt-out class — stockholders in the class period cannot exclude themselves from the settlement, but they must file a claim to receive any payment.

What Is the GreenLight Biosciences Lawsuit About?

On May 30, 2023, GreenLight Biosciences announced it had entered into an agreement to be acquired by Fall Line Capital LLC in a $45.5 million all-cash deal. Under the merger agreement, Fall Line would acquire all outstanding shares of GreenLight common stock for $0.30 per share.

Investigators noted that the $0.30 merger consideration was below the $2.30 median analyst price target for the company, and at least one analyst had set a price target of $4.00 per share — $3.70 above the merger price. Shareholders filed a class action in the Delaware Court of Chancery, alleging the board failed to maximize stockholder value and shortchanged investors in the process.

The lawsuit alleged GreenLight’s directors, officers, and certain stockholders breached their fiduciary duties in connection with the acquisition by Fall Line Capital LLC, and that the transaction disclosures contained material misrepresentations and that the merger was unfair to stockholders. The defendants deny all allegations of wrongdoing but agreed to pay $2,000,000 to resolve the litigation.

Related article: Dove Healthcare Data Breach Settlement, Are You Eligible to Claim Up to $3,000? Deadline is July 6, 2026

What Specific Concerns Did Shareholders Raise?

Investigators noted the transaction agreement unreasonably limited competing bids for GreenLight by imposing a significant penalty if GreenLight accepted a superior bid, and that GreenLight insiders would receive substantial benefits as part of change-of-control arrangements.

Questions also arose over whether all information regarding the sales process and the valuation of the transaction would be fully and fairly disclosed to stockholders before they tendered their shares. These concerns about process fairness and disclosure accuracy formed the core of the class action that ultimately produced this settlement.

Who Is Eligible to File a Claim?

• You may qualify if you were a record holder of GreenLight Biosciences Holdings (GRNA) common stock at any time between June 21, 2023 and July 20, 2023, inclusive.
• You may qualify if your shares were exchanged for $0.30 per share when the merger closed on July 24, 2023.
• You may qualify if you are an individual investor, an institution, a trust, an estate, or any other entity that held eligible GRNA shares during the class period.
• You may qualify if you are an executor, administrator, trustee, heir, or assign submitting on behalf of an eligible holder — provided you supply proof of authority with your claim form.
• You do not qualify if your shares were excluded from the merger (check your brokerage records to confirm your shares were cashed out at $0.30).
• Important: You cannot opt out of the class. However, you must actively file a claim to receive any payment — doing nothing means you receive nothing.

How Much Can GreenLight Stockholders Receive?

The $2,000,000 settlement fund distributes payments on a pro rata basis — meaning each class member’s payment depends on how many shares they held relative to the total valid claims submitted.

Estimated gross distribution: approximately $0.06 per share After deducting court-approved fees and administration costs (estimated at approximately $0.02 per share), the estimated net payment is approximately $0.04 per share.

The settlement fund breakdown is as follows:

• Attorneys’ fees: Up to $500,000
• Attorneys’ expenses: Up to $100,000
• Service awards to lead plaintiffs: Up to $3,000 each ($12,000 total)
• Cash payments to eligible class members: Remainder of the fund after all deductions

Key pro rata rules to understand:

• Final payments may be higher or lower depending on the total number of valid claims submitted.
• Class members whose calculated payment falls below $10.00 will not receive a payout but remain bound by the settlement terms.
• If total recognized claims exceed the net settlement fund, the administrator will reduce all payments proportionally.

How to File a GreenLight Biosciences Settlement Claim

Step 1 — Visit the official settlement website at rg2claims.com/greenlight.html and click “Notice/Claim Form Filing.”

Step 2 — Choose to file online at claimsettlementportal.com/greenlight or download and print the PDF claim form.

Step 3 — Enter your personal details, including your Social Security number or taxpayer identification number (required for all claimants).

Step 4 — Enter the number of GreenLight common stock shares you held at the expiration of the tender offer on July 20, 2023, that were cashed out at $0.30 per share on July 24, 2023.

Step 5 — Upload or attach your supporting documentation — acceptable proof includes broker confirmation slips, trade confirmations, screenshots of broker account holdings, or authorized statements from your broker or financial institution.

Step 6 — Submit your claim online or mail the completed form postmarked by July 29, 2026, and save your confirmation for your records.

Mailing address: In re GreenLight Bio Merger Stockholder Litigation, c/o RG/2 Claims Administration LLC, P.O. Box 59479, Philadelphia, PA 19102-9479

Estimated time to complete: 10–15 minutes (longer if you need to gather brokerage records)

Important Deadlines & Dates

Milestone	Date
Merger Announced	May 30, 2023
Tender Offer Period Begins	June 21, 2023
Tender Offer Expires	July 20, 2023
Merger Closes ($0.30/share paid)	July 24, 2023
Lawsuit Filed (Delaware Chancery)	2024
Settlement Notice Published	April 10, 2026
Objection Deadline	June 15, 2026
Fairness Hearing	June 29, 2026 at 1:30 p.m.
Claim Filing Deadline	July 29, 2026
Expected Payment Date	TBD (after final court approval and claims processing)

Frequently Asked Questions

Do I need a lawyer to file a claim?

 No. You do not need an attorney to submit a proof of claim. The process is straightforward — visit rg2claims.com/greenlight.html, gather your brokerage records showing your GRNA holdings during June 21–July 20, 2023, and complete the claim form online or by mail.

Is this GreenLight Biosciences settlement legitimate? 

Yes. This is a court-supervised class action settlement pending in the Delaware Court of Chancery (Case No. 2024-1020-KSJM). RG/2 Claims Administration LLC, a professional settlement administrator, administers the claims process. You can verify details by calling (866) 742-4955 or emailing [email protected].

When will I receive my payment?

The fairness hearing takes place on June 29, 2026. If the Court grants final approval and no appeals delay the process, the settlement administrator will distribute payments after it processes all valid claims. Exact timing is TBD but expect payments in late 2026 or early 2027.

What if I missed the claim deadline?

If you miss the July 29, 2026 deadline, you will not receive any payment. Because this is a non-opt-out class, you will still be bound by the settlement and release your right to sue separately — even without filing a claim. Contact the administrator at (866) 742-4955 if you have questions about your deadline.

Will this settlement payment affect my taxes?

 Payments from merger-related stockholder settlements may be taxable depending on your original cost basis and individual tax situation. The administrator will issue appropriate tax forms to claimants who receive payments. Consult a tax professional for advice specific to your situation.

Why was the $0.30 per share price considered unfair by stockholders? 

Multiple law firms noted that the $0.30 merger price was significantly below the $2.30 median analyst price target, and at least one analyst had set a price target of $4.00 per share — more than thirteen times the deal price. The lawsuit alleged the board accepted an inadequate price without fully exploring competing offers or providing shareholders with complete information to evaluate the deal.

Can I still object to the settlement terms? 

Yes, but only if you act before June 15, 2026. Written objections must be received by the Delaware Court of Chancery by that date. You may also request to speak at the June 29, 2026 fairness hearing. Consult an attorney before objecting, as the process carries specific procedural requirements.

I held GRNA shares through a brokerage — do I still need to file?

 Yes. Holding shares through a broker does not automatically enroll you in the settlement payout. You must actively file a proof of claim and provide supporting documentation by July 29, 2026. Your broker will not file on your behalf.

Sources & References

1. Official Settlement Website — rg2claims.com/greenlight.html
2. Official Settlement Notice (PDF) — RG/2 Claims Administration

Last Updated: April 17, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.